A Study to Evaluate Safety and Immunogenicity of Trivalent Influenza Vaccine, Formulation 2015 Southern Hemisphere, When Administered to Healthy Adult Subjects.
Clinical trial NCT02427750 · COMPLETED
Trial details
- NCT number
- NCT02427750
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2015-05-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.